C
SAGE

Covestor’s Sage Therapeutics SAGE Stock Holding History

Covestor’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-39,473
Closed -$360K – 2703
2025
Q2 		$360K Buy
39,473
+19,694
+100% +$145K 0.21% 56
2025
Q1 		$157K Buy
19,779
+19,772
+282,457% +$145K 0.1% 237
2024
Q4 		$0 Buy
7
+1
+17% +$6 ﹤0.01% 2669
2024
Q3 		$0 Sell
6
-1
-14% -$9 ﹤0.01% 2685
2024
Q2 		$0 Buy
7
+4
+133% +$51 ﹤0.01% 2682
2024
Q1 		$0 Sell
3
-1
-25% -$23 ﹤0.01% 2665
2023
Q4 		$0 Sell
4
-46
-92% -$912 ﹤0.01% 2639
2023
Q3 		$1K Buy
50
+45
+900% +$1.3K ﹤0.01% 1988
2023
Q2 		$0 Sell
5
-280
-98% -$13.9K ﹤0.01% 2578
2023
Q1 		$12K Buy
285
+3
+1% +$129 0.01% 1232
2022
Q4 		$11K Buy
282
+275
+3,929% +$10.5K 0.01% 1294
2022
Q3 		$0 Hold
7
– – ﹤0.01% 2506
2022
Q2 		$0 Sell
7
-97
-93% -$3.25K ﹤0.01% 2302
2022
Q1 		$3K Sell
104
-4
-4% -$150 ﹤0.01% 1623
2021
Q4 		$5K Buy
+108
New +$4.52K 0.01% 1336

Other funds holding SAGE

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Covestor's SAGE Position: Q3 2025 in Review

Covestor sold out of Sage Therapeutics (SAGE) in Q3 2025, closing a stake of 39,473 shares — an estimated $360K sold.

Covestor first reported a position in SAGE in Q4 2021 and held it in 15 quarters. The position peaked at $360K in Q2 2025. 5 funds tracked by Wall St. Rank hold SAGE as of Q3 2025.

  • Covestor reported no remaining Sage Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Covestor sold 39,473 Sage Therapeutics shares in Q3 2025, an estimated $360K.
  • Covestor first reported a position in Sage Therapeutics in Q4 2021 and held it in 15 quarters.
  • Covestor's Sage Therapeutics position peaked at $360K in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2025.

Based on Covestor's 13F filing for Q3 2025, filed 30 Oct 2025.